Aerogen, the global leader in aerosol drug delivery, has been selected by members of the American Association for Respiratory Care to receive the prestigious 2017 AARC Zenith Award. This award, which is presented to only six companies out of more than 300, is a way for AARC members to recognize manufacturers and service organizations that have done outstanding work for them and their employers.
“Aerogen typifies the qualities represented in the criteria and, because of this; we salute you and your employees”, said Thomas J. Kallstrom, MBA, RRT, FAARC, Executive Director/CEO
“We are honored to receive our fourth Zenith Award from the over 47,000 respiratory care professionals in AARC,” said John Power, Managing Director and CEO of Aerogen.. “Aerogen is proud to have allied with respiratory care professionals in the United States and around the world to deliver superior aerosol drug delivery capability to patients who need critical drugs to breathe better and survive their acute conditions. This award is evidence of the support we work hard to give them every day, with every product they use, and I wish to thank them for their continued vote of confidence in using our products. I could not be more proud of the outstanding team at Aerogen that has worked to develop the technology and improve it for better patient results and easier use.”
Aerogen officially received the Award on Wednesday, October 4th at the Association’s 63rd International Respiratory Congress this October in Indianapolis, IN.